Verastem, Inc. VSTM
7.74
(0.06)
(0.77%)
as of 25 Sep
- Market cap
- $694.6M
- P/E
- 0.0×
Follow VSTM
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
4.37 | 10.51 | 13.08 | 24.87 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(8.71) | (10.00) | (17.86) | (17.84) | |
P/B ratio |
7.65 | 6.37 | 9.35 | 0.00 | |
Price to Tangible BV |
11.21 | 7.94 | 13.12 | 0.00 | |
EV/Sales |
3.77 | 8.52 | 10.17 | 22.96 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(2.03) | (2.80) | (3.03) | (4.49) | |
EV/FCF |
(2.03) | (2.80) | (3.03) | (4.49) | |
Quick Ratio |
2.12 | 2.87 | 2.96 | 2.42 | |
Current Ratio |
2.25 | 3.04 | 3.09 | 2.58 | |
Net Debt/EBITDA |
1.92 | 2.43 | 3.12 | 1.47 | |
Debt/Assets |
35.72% | 32.10% | 30.97% | 44.17% | |
Debt/Equity |
1.48 | 0.89 | 1.33 | (5.03) | |
Asset Turnover |
0.43 | 0.28 | 0.24 | 0.17 | |
Operating CF/Net income |
1.27 | 1.42 | 0.91 | 0.37 | |
Capex/Depreciation |
0.00 | 0.00 | (4.82) | (30.22) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
103.14% | 204.69% | 180.62% | 257.86% | |
Selling, General and Administrative Expense of Revenue |
68.39% | 119.43% | 139.42% | 186.87% | |
Intangible Assets out of Total Assets |
0.08 | 0.07 | 0.07 | 0.09 | |
Share Based Compensation of Revenue |
8.56% | 10.96% | 11.55% | 19.37% | |
Graham Net Nets |
0.05 | 0.11 | 0.06 | (0.06) | |
Graham Number |
0.00 | 0.00 | 0.00 | 4.47 | |
Earnings Yield |
(64.40%) | (47.17%) | (40.03%) | (47.49%) | |
Free Cash Flow Yield |
(42.42%) | (28.98%) | (25.70%) | (20.54%) | |
Revenue per Share |
0.40 | 0.19 | 0.25 | 0.15 | |
Operating CF per Share |
(0.44) | (0.53) | (0.43) | (0.49) | |
Capex per Share |
0.00 | 0.00 | (0.02) | (0.11) | |
Free Cash Flow per Share |
(0.44) | (0.53) | (0.45) | (0.61) | |
Cash per Share |
1.36 | 1.85 | 2.96 | 1.88 | |
Shareholders Equity per Share |
0.50 | 0.83 | 0.83 | (0.21) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.50 | 0.83 | 0.83 | (0.21) | |
Free Cash Flow |
(43.91) | (52.12) | (31.30) | (44.49) | |
Working Capital |
98.03 | 136.06 | 151.15 | 94.34 | |
Capital Expenditures |
— | — | (1.34) | (8.28) | |
Net Current Asset Value |
19.63 | 56.87 | 34.17 | (38.32) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.08 | 0.74 | |
Net Profit Margin |
(86.51%) | (195.98%) | (187.72%) | (876.34%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
15.68 | 5.28 | 4.61 | 3.56 | |
Average Payables |
13.02 | 8.40 | 8.24 | 7.16 | |
Average Inventory |
1.78 | 4.30 | 4.07 | 3.08 | |
Average Assets |
201.39 | 179.75 | 173.99 | 151.62 | |
Average Common Equity |
43.02 | 24.67 | 14.15 | (2.23) |
Columns are period end dates